Retatrutide Triple Agonist: GLP-1/GIP/Glucagon Mechanism Deep Dive

Research Guide | 2026-05-01 | 7.4 min read

Deep dive into retatrutide's triple agonism: GLP-1, GIP, and glucagon receptor pharmacology, thermogenesis, lipolysis, and the pharmacology of triple incretin targeting.

Deep dive into retatrutide's triple agonism: GLP-1, GIP, and glucagon receptor pharmacology, thermogenesis, lipolysis, and the pharmacology of triple incretin targeting.

ZePeptide content is for lawful laboratory and in-vitro research sourcing. Products are not supplied for human or veterinary use.